Center-Authored Papers

Filters: Author is Overbaugh, Julie  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
McClelland SR, Richardson BA, Cherutich P, Mandaliya K, John-Stewart G, Miregwa B, Odem-Davis K, Jaoko W, Kimanga D, Overbaugh J.  2015.  A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers. AIDS (London, England). 29(17):2279–2286. Abstract
A
Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, Richardson BA, Dong T, Iversen AK, Mbori-Ngacha D, Overbaugh J et al..  2009.  Acute cytomegalovirus infection in Kenyan HIV-infected infants.. AIDS (London, England). 23(16):2173-81. Abstract
Richardson BA, Nduati R, Mbori-Ngacha D, Overbaugh J, John-Stewart GC.  2008.  Acute HIV infection among Kenyan infants.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(2):289-95. Abstract
Humes D, Overbaugh J.  2011.  Adaptation of subtype a human immunodeficiency virus type 1 envelope to pig-tailed macaque cells.. Journal of virology. 85(9):4409-20. Abstract
Boyd DF, Sharma A, Humes D, Cheng-Mayer C, Overbaugh J.  2016.  Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance.. PLoS pathogens. 12(7):e1005727. Abstract
Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, Overbaugh J, Berkley J, Sanders EJ, Chung MH et al..  2008.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.. AIDS (London, England). 22(13):1601-9. Abstract
Piantadosi A, Humes D, Chohan B, McClelland SR, Overbaugh J.  2009.  Analysis of the percentage of human immunodeficiency virus type 1 sequences that are hypermutated and markers of disease progression in a longitudinal cohort, including one individual with a partially defective Vif.. Journal of virology. 83(16):7805-14. Abstract
Overbaugh J, Morris L.  2012.  The Antibody Response against HIV-1.. Cold Spring Harbor perspectives in medicine. 2(1):a007039. Abstract
Forthal DN, Landucci G, Chohan B, Richardson BA, Scott McClelland R, Jaoko W, Blish C, Overbaugh J.  2013.  Antibody-dependent cell-mediated virus inhibition (ADCVI) antibody activity does not correlate with risk of HIV-1 superinfection.. Journal of acquired immune deficiency syndromes (1999). Abstract
Graham SM, Masese L, Gitau R, Jalalian-Lechak Z, Richardson BA, Peshu N, Mandaliya K, Kiarie JN, Jaoko W, Ndinya-Achola J et al..  2010.  Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.. The Journal of infectious diseases. 202(10):1538-42. Abstract
Lehman DA, John-Stewart GC, Overbaugh J.  2009.  Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance.. PLoS medicine. 6(10):e1000169. Abstract
Graham SM, Jalalian-Lechak Z, Shafi J, Chohan V, Deya RW, Jaoko W, Mandaliya KN, Peshu NM, Overbaugh J, McClelland SR.  2012.  Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNA.. Journal of acquired immune deficiency syndromes (1999). Abstract
Graham SM, Jalalian-Lechak Z, Shafi J, Chohan V, Deya RW, Jaoko W, Mandaliya KN, Peshu NM, Overbaugh J, McClelland SR.  2012.  Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNA.. Journal of acquired immune deficiency syndromes (1999). 60(5):511-8. Abstract
Blish CA, Dogan OC, Jaoko W, McClelland SR, Mandaliya K, Odem-Davis K, Richardson BA, Overbaugh J.  2014.  Association between Cellular Immune Activation, Target Cell Frequency, and Risk of Human Immunodeficiency Virus Type-1 Superinfection.. Journal of virology. 88(10):5894-9. Abstract
B
Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J.  2011.  The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.. Journal of virology. 85(11):5252-61. Abstract
Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland SR, Overbaugh J.  2009.  Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.. Journal of virology. 83(19):10269-74. Abstract
Lohman-Payne B, Slyker JA, Moore S, Maleche-Obimbo E, Wamalwa DC, Richardson BA, Rowland-Jones S, Mbori-Ngacha D, Farquhar C, Overbaugh J et al..  2012.  Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission.. AIDS (London, England). 26(16):2007-16. Abstract
Farquhar C, Lohman-Payne B, Overbaugh J, Richardson BA, Mabuka J, Bosire R, Mbori-Ngacha D, John-Stewart G.  2011.  Breast Milk HIV-1 RNA Levels and Female Sex Are Associated With HIV-1-Specific CD8+ T-Cell Responses in HIV-1-Exposed, Uninfected Infants in Kenya.. The Journal of infectious diseases. 204(11):1806-10. Abstract
Cortez V, Wang B, Dingens A, Chen MM, Ronen K, Georgiev IS, McClelland SR, Overbaugh J.  2015.  The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection.. PLoS pathogens. 11(7):e1004973. Abstract
C
Blish CA, Dogan OC, Jaoko W, McClelland SR, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J.  2012.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.. AIDS (London, England). 26(5):643-6. Abstract
Choi RY, Levinson P, Guthrie BL, Payne B, Bosire R, Liu AY, Hirbod T, Kiarie J, Overbaugh J, Stewart GJ et al..  2012.  Cervicovaginal HIV-1 Neutralizing IgA Detected among HIV-1-Exposed Seronegative Female Partners in HIV-1-Discordant Kenyan Couples.. AIDS (London, England). 26(17):2155-2163. Abstract
Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Graham SM, Shafi J, Kiarie J, Overbaugh J, McClelland SR.  2015.  Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.. AIDS (London, England). 29(9):1077-85. Abstract
Roxby AC, Fredricks DN, Odem-Davis K, Ásbjörnsdóttir K, Masese L, Fiedler TL, De Rosa S, Jaoko W, Kiarie JN, Overbaugh J et al..  2016.  Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.. Journal of acquired immune deficiency syndromes (1999). 71(4):359-66. Abstract
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu S-lok, Stamatatos L.  2008.  Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.. Journal of virology. 82(12):5912-21. Abstract
Goo L, Jalalian-Lechak Z, Richardson BA, Overbaugh J.  2012.  A Combination of Broadly Neutralizing HIV-1 Monoclonal Antibodies Targeting Distinct Epitopes Effectively Neutralizes Variants Found in Early Infection.. Journal of virology. 86(19):10857-61. Abstract